180 related articles for article (PubMed ID: 31128502)
1. Comparison of quetiapine immediate- and extended-release formulations for bipolar depression: A systematic review and network meta-analysis of double-blind, randomized placebo-controlled trials.
Kishi T; Ikuta T; Sakuma K; Matsuda Y; Iwata N
J Psychiatr Res; 2019 Aug; 115():121-128. PubMed ID: 31128502
[TBL] [Abstract][Full Text] [Related]
2. Lurasidone, olanzapine, and quetiapine extended-release for bipolar depression: A systematic review and network meta-analysis of phase 3 trials in Japan.
Kishi T; Yoshimura R; Sakuma K; Okuya M; Iwata N
Neuropsychopharmacol Rep; 2020 Dec; 40(4):417-422. PubMed ID: 32902200
[TBL] [Abstract][Full Text] [Related]
3. Quetiapine extended-release vs olanzapine for Japanese patients with bipolar depression: A Bayesian analysis.
Kishi T; Ikuta T; Matsuda Y; Iwata N
Neuropsychopharmacol Rep; 2019 Sep; 39(3):256-259. PubMed ID: 31283865
[TBL] [Abstract][Full Text] [Related]
4. Quetiapine: a review of its use in the management of bipolar depression.
Sanford M; Keating GM
CNS Drugs; 2012 May; 26(5):435-60. PubMed ID: 22519923
[TBL] [Abstract][Full Text] [Related]
5. Multi-center, randomized, double-blind, placebo-controlled study of quetiapine extended-release formulation in Japanese patients with bipolar depression.
Murasaki M; Koyama T; Kanba S; Takeuchi M; Shimizu Y; Arita E; Kuroishi K; Takeuchi M; Kamei S
Psychopharmacology (Berl); 2018 Oct; 235(10):2859-2869. PubMed ID: 30069587
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of quetiapine XR vs. placebo as concomitant treatment to mood stabilizers in the control of subthreshold symptoms of bipolar disorder: Results from a pilot, randomized controlled trial.
Garriga M; Solé E; González-Pinto A; Selva-Vera G; Arranz B; Amann BL; Saiz-Ruiz J; Pérez-Blanco J; Vieta E
Eur Neuropsychopharmacol; 2017 Oct; 27(10):959-969. PubMed ID: 28882405
[TBL] [Abstract][Full Text] [Related]
7. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D
Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797
[TBL] [Abstract][Full Text] [Related]
8. Long-term mood/antidepressant effects of quetiapine extended-release formulation: an open-label, non-controlled extension study in Japanese patients with bipolar depression.
Kanba S; Murasaki M; Koyama T; Takeuchi M; Shimizu Y; Arita E; Kuroishi K; Takeuchi M; Kamei S
BMC Psychiatry; 2019 Jun; 19(1):198. PubMed ID: 31242884
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of extended-release quetiapine fumarate in youth with bipolar depression: an 8 week, double-blind, placebo-controlled trial.
Findling RL; Pathak S; Earley WR; Liu S; DelBello MP
J Child Adolesc Psychopharmacol; 2014 Aug; 24(6):325-35. PubMed ID: 24956042
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of quetiapine extended release monotherapy in bipolar depression: a multi-center, randomized, double-blind, placebo-controlled trial.
Li H; Gu N; Zhang H; Wang G; Tan Q; Yang F; Ning Y; Zhang H; Lu Z; Xu X; Shi J; Gao C; Li L; Zhang K; Tian H; Wang X; Li K; Li H; Xu Y; Xie S; Yu X
Psychopharmacology (Berl); 2016 Apr; 233(7):1289-97. PubMed ID: 26911380
[TBL] [Abstract][Full Text] [Related]
11. Self-reported sedation profile of quetiapine extended-release and quetiapine immediate-release during 6-day initial dose escalation in bipolar depression: a multicenter, randomized, double-blind, phase IV study.
Riesenberg RA; Baldytcheva I; Datto C
Clin Ther; 2012 Nov; 34(11):2202-11. PubMed ID: 23059166
[TBL] [Abstract][Full Text] [Related]
12. Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysis.
Ostacher M; Ng-Mak D; Patel P; Ntais D; Schlueter M; Loebel A
World J Biol Psychiatry; 2018 Dec; 19(8):586-601. PubMed ID: 28264635
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of atypical antipsychotics for acute bipolar depression: a network meta-analysis.
Kadakia A; Dembek C; Heller V; Singh R; Uyei J; Hagi K; Nosaka T; Loebel A
BMC Psychiatry; 2021 May; 21(1):249. PubMed ID: 33975574
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of FDA-approved atypical antipsychotics for the treatment of bipolar depression: a systematic review and network meta-analysis.
Li S; Xu C; Hu S; Lai J
Eur Psychiatry; 2024 Mar; 67(1):e29. PubMed ID: 38487836
[TBL] [Abstract][Full Text] [Related]
15. Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial.
Pagsberg AK; Jeppesen P; Klauber DG; Jensen KG; Rudå D; Stentebjerg-Olesen M; Jantzen P; Rasmussen S; Saldeen EA; Lauritsen MG; Bilenberg N; Stenstrøm AD; Nyvang L; Madsen S; Werge TM; Lange T; Gluud C; Skoog M; Winkel P; Jepsen JRM; Fagerlund B; Correll CU; Fink-Jensen A
Lancet Psychiatry; 2017 Aug; 4(8):605-618. PubMed ID: 28599949
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression.
Suppes T; Datto C; Minkwitz M; Nordenhem A; Walker C; Darko D
J Affect Disord; 2010 Feb; 121(1-2):106-15. PubMed ID: 19903574
[TBL] [Abstract][Full Text] [Related]
17. Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies.
Vieta E; Mullen J; Brecher M; Paulsson B; Jones M
Curr Med Res Opin; 2005 Jun; 21(6):923-34. PubMed ID: 15969892
[TBL] [Abstract][Full Text] [Related]
18. Quetiapine for acute bipolar depression: a systematic review and meta-analysis.
Suttajit S; Srisurapanont M; Maneeton N; Maneeton B
Drug Des Devel Ther; 2014; 8():827-38. PubMed ID: 25028535
[TBL] [Abstract][Full Text] [Related]
19. Extended-release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: results of a randomized, placebo-controlled, double-blind study.
Bauer M; Pretorius HW; Constant EL; Earley WR; Szamosi J; Brecher M
J Clin Psychiatry; 2009 Apr; 70(4):540-9. PubMed ID: 19358791
[TBL] [Abstract][Full Text] [Related]
20. Systematic Review and Network Meta-analysis: Efficacy and Safety of Second-Generation Antipsychotics in Youths With Bipolar Depression.
DelBello MP; Kadakia A; Heller V; Singh R; Hagi K; Nosaka T; Loebel A
J Am Acad Child Adolesc Psychiatry; 2022 Feb; 61(2):243-254. PubMed ID: 34420839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
